CONCLUSION: We found that cord blood plasma metabolomics reveals intriguing and specific differences between ASD and control samples. While some of differences are supported by evidence, these alterations have not previously been extended to the prenatal period. Future work will investigate concordance with maternal blood metabolomics to determine maternal-fetal pathways.
